AI Pathology Test Outperforms Oncotype DX Gold Standard in HR+/HER2- Patients
kjgeras · x · 2026-07-06
In HR+/HER2- patients (n=858), this AI pathology test was directly compared against the 20-year clinical gold standard Oncotype DX (21-gene assay). It achieved a C-index of 0.67 vs. 0.61 and outperformed Oncotype DX across multiple thresholds in decision curve analysis.
More from Research
- 3D ResNet Paper Crosses 3,000 Citations Eight Years After CVPR 2018 — HirokatuKataoka · 2026-09-11
- Jeff Heaton's Intro to the Math of Neural Networks eBook Is Free to Download — blaizedsouza · 2026-09-11
- Mathematician Daniel Litt Launches Problem Repo to Track Human vs AI Progress: 15 Problems, 1 Solved — littmath · 2026-09-11
- Open ECDSA.fail challenge uses AI agents to shrink Shor's-algorithm quantum circuits for Bitcoin keys — StefanoGogioso · 2026-09-11
- Alex Townsend posts 200 open problems in numerical linear algebra for humans and AI agents — IgorCarron · 2026-09-11
- Navier-Stokes, Riemann, P vs NP: what this week's math buzzwords mean for you — koltregaskes · 2026-09-11